Adoption of Abiraterone and Enzalutamide by Urologists

OBJECTIVE: To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by medical oncologists. METHODS: Using the Medicare Par...

詳細記述

保存先:
書誌詳細
出版年:Urology
主要な著者: Caram, Megan E.V., Kaufman, Samuel R., Modi, Parth K., Herrel, Lindsey, Oerline, Mary, Ross, Ryan, Skolarus, Ted A., Hollenbeck, Brent K., Shahinian, Vahakn
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711811/
https://ncbi.nlm.nih.gov/pubmed/31136769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2019.05.012
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料